Showing results (231-240 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Nutritional Biochemistry|December 12, 2018
Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicityLap Ho, Danyue Zhao, Kenjiro Ono, et al.
Cancers|July 29, 2025
Plasma WFDC2 (HE4) as a Predictive Biomarker for Clinical Outcomes in Cancer Patients Receiving Anti-PD-1 Therapy: A Pilot StudyMakoto Watanabe, Katsuaki Ieguchi, Takashi Shimizu, et al.
Biomedicines|December 30, 2025
Eosinophils and the Efficacy of Immune Checkpoint Inhibitors Across Multiple Cancers: A Retrospective StudyRisako Suzuki, Ryotaro Ohkuma, Makoto Watanabe, et al.
Frontiers in Oncology|July 29, 2025
Elevated plasma levels of WAP four-disulfide core domain 2 as a potential prognostic biomarker for various cancersMakoto Watanabe, Katsuaki Ieguchi, Nobuyuki Onishi, et al.
Journal of Epidemiology|January 16, 2019
Associations Between Metal Levels in Whole Blood and IgE Concentrations in Pregnant Women Based on Data From the Japan Environment and Children's StudyMayumi Tsuji, Chihaya Koriyama, Yasuhiro Ishihara, et al.
In Vivo (Athens, Greece)|February 25, 2018
Protection of Differentiating Neuronal Cells from Amyloid β Peptide-induced Injury by Alkaline Extract of Leaves of Sasa senanensis RehderHiroshi Sakagami, Mayumi Tsuji, Mineko Tomomura, et al.
Environmental Health and Preventive Medicine|March 7, 2019
For making a declaration of countermeasures against the falling birth rate from the Japanese Society for Hygiene: summary of discussion in the working group on academic research strategy against an aging society with low birth rateKyoko Nomura, Kanae Karita, Atsuko Araki, et al.
Oncology Letters|August 10, 2023
Monocyte subsets associated with the efficacy of anti‑PD‑1 antibody monotherapyRyotaro Ohkuma, Yuki Fujimoto, Katsuaki Ieguchi, et al.
Frontiers in Immunology|September 24, 2025
Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
Frontiers in Immunology|April 13, 2026
Correction: Tumor Akkermansia muciniphila predicts clinical response to immune checkpoint inhibitors in non-small-cell lung cancer patients with low PD-L1 expressionTakashi Shimizu, Ryotaro Ohkuma, Mayumi Homma, et al.
Pageof 26